跳至主要内容
临床试验/NCT00856882
NCT00856882已完成不适用

The Effects of Soy Protein and/or Isoflavones on Glycemic Control, Insulin Sensitivity and Cardiovascular Risk Factors-a Six Months RCT Among Postmenopausal Women

Chinese University of Hong Kong0 个研究点开始时间: 2007年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成

研究概览

简要总结

The investigators propose to perform a double-blind, randomized placebo-controlled trial to examine the hypothesis that soy protein with isoflavones could improve glycemic control, insulin sensitivity and decrease cardiovascular risk factors in postmenopausal women with prediabetes.

研究设计

研究类型
Interventional

入排标准

年龄范围
46 Years 至 70 Years(Adult, Older Adult)
性别
Female
接受健康志愿者
是

入选标准

  • •Hong Kong Chinese menopausal women aged 46-70 years with prediabetes or early untreated diabetes

排除标准

  • •Women with breast, ovary or other cancers in recent 5-year
  • •Severe renal or liver dysfunction
  • •Women with androgen excess
  • •Current use or recent (3-month)use of any drug or treatment for glycemic control, lipid improvement, weight reduction; Subjects with known soy or milk allergy.

研究组 & 干预措施

milk protein only

Placebo Comparator

干预措施: milk protein (Dietary Supplement)

soy protein and isoflavones

Experimental

干预措施: isoflavones (Dietary Supplement)

milk protein and isoflavones

Experimental

干预措施: isoflavones (Dietary Supplement)

milk protein and isoflavones

Experimental

干预措施: milk protein (Dietary Supplement)

soy protein and isoflavones

Experimental

干预措施: soy protein (Dietary Supplement)

研究者

申办方类型
Other

相似试验

The Effects of Soy Protein and Isoflavones on... | 临床试验